Hodgkin's Disease News

12-Year-Old Boy Who Donated His Hair to Kids with Cancer Is Diagnosed with Stage 4 Hodgkin's Lymphoma 6 Months ... - PEOPLE.com



PEOPLE.com
 
12-Year-Old Boy Who Donated His Hair to Kids with Cancer Is Diagnosed with Stage 4 Hodgkin's Lymphoma 6 Months ... 
PEOPLE.com
Hodgkin's lymphoma is a rare cancer that affects the body's lymphatic system and inhibits the body's ability to ward off infections. The American Cancer Society says about 10- to 15-percent of cases involve children and teenagers, and in 2017, there ...

 


USC study finds potential new treatments for Hodgkin's lymphoma - USC News



USC News
 
USC study finds potential new treatments for Hodgkin's lymphoma 
USC News
A study published in The Journal of Pathology examines the role of the enzyme monoamine oxidase-A (MAO-A) in Hodgkin's lymphoma. The study was led by USC University Professor Jean C. Shih, whose pioneering research has provided insights into the ...

 


3D Signatures Announces Completion of Stage 3 of Hodgkin's Lymphoma Test Validation Program - Nasdaq



3D Signatures Announces Completion of Stage 3 of Hodgkin's Lymphoma Test Validation Program 
Nasdaq
TORONTO, Oct. 10, 2017 (GLOBE NEWSWIRE) -- 3D Signatures Inc. (TSX-V:DXD) (OTCQB:TDSGF) (FSE:3D0) (the "Company" or "3DS"), is pleased to announce that, on September 30, 2017, the Company completed the clinical trial component (the "Clinical ...

and more » 


NexImmune and The Leukemia & Lymphoma Society enter partnership for the development of AIM ACT? in AML ... - GlobeNewswire (press release)



NexImmune and The Leukemia & Lymphoma Society enter partnership for the development of AIM ACT? in AML ... 
GlobeNewswire (press release)
The Leukemia & Lymphoma Society (R) (LLS) is the world's largest voluntary health agency dedicated to blood cancer. The LLS mission: Cure leukemia, lymphoma, Hodgkin's disease and myeloma, and improve the quality of life of patients and their families.

and more » 


New Belfast Giants star Spiro Goulakos reveals how ice hockey was an escape in battle with cancer - Belfast Telegraph



Belfast Telegraph
 
New Belfast Giants star Spiro Goulakos reveals how ice hockey was an escape in battle with cancer 
Belfast Telegraph
Belfast Giants' new Canadian signing Spiro Goulakos has revealed how ice hockey helped him during his battle with cancer. The 27-year-old from Montreal was diagnosed with stage two Hodgkin's lymphoma while at university in New York. ?I was fortunate ...

 


Cancer slows but can't stop a UO discovery on protein motion - AroundtheO



AroundtheO
 
Cancer slows but can't stop a UO discovery on protein motion 
AroundtheO
Jeremy Copperman, a doctoral student leading it, was diagnosed with Hodgkin's lymphoma in the final year of his doctoral studies in physics. His work slowed amid six months of chemotherapy. Graduate students Eric Beyerle and Hadi Dinpajooh discuss ...

 


A Q&A on New Developments in Breast-cancer Treatments - Business West (blog)



Montreal Gazette
 
A Q&A on New Developments in Breast-cancer Treatments 
Business West (blog)
... mutation placing you at greater risk to breast cancer, such as the BRCA mutation, previous history of chest radiation, such as for Hodgkin's lymphoma, or a family history of breast cancer that places you at a greater than 20-25% lifetime risk for ...
AAMC: Know the facts about genetic testing for breast cancer CapitalGazette.com

all 420 news articles » 


Woman Seeks Answers in Slaying of Father in 2000 | Alabama News - U.S. News & World Report



Woman Seeks Answers in Slaying of Father in 2000 | Alabama News 
U.S. News & World Report
TUSCALOOSA, Ala. (AP) ? Cheryl Mu'min has spent 17 years seeking answers in the beating death of her father, an aging Vietnam veteran and retired school ...

 


6 Top Biotech Companies In Innovation Earn Recognition In New ... - Nasdaq



6 Top Biotech Companies In Innovation Earn Recognition In New ... 
Nasdaq
Cure is a strong word when it comes to treating cancer and other deadly diseases, but Brad Loncar is among the biotech stock analysts and investors.

and more » 


Brentuximab Vedotin Receives Breakthrough Therapy Designation ... - OncLive



OncLive
 
Brentuximab Vedotin Receives Breakthrough Therapy Designation ... 
OncLive
The FDA has awarded brentuximab vedotin (Adcetris) a breakthrough therapy designation for the first-line treatment of patients with classical Hodgkin lymphoma ...

and more »